A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
Wen LiuHuilan LiHui ShengXiaohua LiuPeidong ChiXueping WangMinjie MaoPublished in: Advances in therapy (2020)
A single EBNA1-IgA exhibits excellent discrimination performance in early diagnosis of NPC and could become a promising marker for NPC screening.